How is α-synuclein (αS) in Alzheimer’s Disease clinically significant? (🧵1/3) #AlzResearch

New in A&D, prospective evaluation in MCI/mild dementia investigating:
🧠Biomarkers
🧠Cognition/olfactory/rapid eye movement sleep behavior disorder (RBD)

alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

So important to understand DSAD! Excited for this research! #AlzResearch

Study Details:
🧠358 adults with DS assessed using amyloid/tau PET and cognitive performance
🧠ChBF and hippocampal volumes negatively associated with AD pathology and positively associated with cog performance
🧠This timeline helps inform future clinical trials #AlzResearch

A&D is excited to support this collaborative research! #AlzResearch

A&D is excited to support this collaborative research! #AlzResearch

How does progressive resistance training (PRT) impact those with subcortical vascular cognitive impairment (SVCI)?

Resistance exercise may slow down cognitive decline in those with vascular cognitive impairment, especially females #AlzResearch

alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

A&D is excited to support this collaborative research! #AlzResearch

A&D is excited to support this work! #AlzResearch #DADM

Check out this full special collection published in A&D! #AlzResearch

Caregiving Science is such a critical topic! Check out this full special collection published in A&D!💜

#AlzResearch

4 #DADM Special Issues open, with submission deadlines in March!

Don't miss out! #AlzResearch

Check out this new special issue in A&D!!

#AlzResearch

Did you present at #AAIC25 in Toronto last year?

Check out your published abstracts now live in A&D!!

#AlzResearch

#AAIC25 Abstracts are now published in Alzheimer's & Dementia, the official journal of the
@alzassociation.bsky.social!

Please check out this thread to find your published abstract based on scientific focus area.

Congratulations to all presenters at #AAIC25!💜

#AlzResearch

A&D is excited to support this collaborative research! #AlzResearch

Check out these amazing results on brain health and cognition from the ACTIVE study out in #TRCI!

This is a MUST READ!👏🧠 #AlzResearch

“The sky is the limit.” Alzheimer’s Association-funded researcher, clinician and music therapist Kendra Ray, Ph.D., shares a message for tomorrow’s girls in science. 🔬 #WomenInScience #AlzResearch

Check out this new publication that utilized wrist-worn accelerometry and neuropsychological tests in over 150 older adults! #AlzResearch

How are temporal physical activity (PA) patterns associated with Alzheimer's risk?

New research in A&D demonstrates:
🟣Lower complexity of daily PA was linked to poorer cognition
🟣Early dementia may reduce complexity of activities
#AlzResearch

alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

A&D is excited to support this collaborative research! #AlzResearch

A&D is excited to support this collaborative work! #AlzResearch

Alzheimer's & Dementia: Call for Papers - DEMENTIA RESEARCH IN LATIN AMERICA The next in the Global Spotlight Series of the journal will spotlight dementia research in Latin America and Caribbean (LAC) countries. The Guest Editors of the Special Issue are Claudia Suemoto, Lucia Crivelli, Jose Avila Funes, and Nilton Custodio.

Alzheimer’s & Dementia Global Spotlight Series: Dementia Research in Latin America LAST CALL📣

Research on dementia in Latin American countries is encouraged across all ADRD research fields. #AlzResearch

⏰Deadline: Dec. 20, 2025

alz-journals.onlinelibrary.wiley.com/hub/journal/...

A&D is excited to support this collaborative research! #AlzResearch

A&D is excited to support this collaborative research! #AlzResearch

Brand new in A&D: Treatment-Related Amyloid Clearance (TRAC) framework article! #AlzResearch

This research is a critical resource for clinicians and scientists!

Check out this new paper on the TRAC framework, a collaborative effort from the @alzassociation.bsky.social! I think this is an excellent publication to review ahead of #CTAD!

#AlzResearch

Treatment‐related amyloid clearance (TRAC): a framework to characterize patients in the era of anti‐amyloid therapies Following regulatory approval of anti-amyloid beta (Aβ) therapies, a better characterization of patients receiving these treatments is needed to guide clinical management and inclusion in future tri.....

⭐New in A&D!⭐

Treatment-Related Amyloid Clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies

Check out the newest recommendations from the @alzassociation.bsky.social-convened workgroup here: alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

#AlzResearch

A&D is excited to support this collaborative research! #AlzResearch

A&D is excited to support this collaborative research! #AlzResearch

A&D is excited to support this collaborative work! #AlzResearch